Should an oral course of flucloxacillin be given to eradicate nasal Staphylococcus aureus carriage in the surgeon and operating‑room nurse?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Flucloxacillin Should NOT Be Used for Decolonization of Nasal S. aureus Carriage in Healthcare Workers

The evidence-based recommendation is to use mupirocin nasal ointment 2% twice daily for 5 days, with or without chlorhexidine gluconate soap, for decolonization of nasal Staphylococcus aureus carriage—not oral flucloxacillin. 1

Why Mupirocin, Not Flucloxacillin

The 2024 European Society of Clinical Microbiology and Infectious Diseases guidelines provide a strong recommendation with moderate certainty of evidence for mupirocin-based decolonization before cardiac and orthopedic surgery 1. This recommendation is based on nine randomized controlled trials conducted between 2002-2020 across multiple countries, demonstrating effectiveness in reducing surgical site infections.

The Evidence Against Oral Flucloxacillin for Decolonization

While older research from 1992 showed that oral antibiotics including dicloxacillin (a related isoxazolyl penicillin) achieved only 75% eradication at early follow-up and ≤50% at late follow-up 2, the current standard of care has evolved to topical mupirocin because:

  • Topical therapy targets the colonization site directly without systemic exposure
  • Oral flucloxacillin has significant drug-drug interaction potential as a weak CYP3A4 inducer 3, affecting narrow therapeutic index drugs
  • Systemic antibiotics promote broader antimicrobial resistance compared to topical agents
  • Mupirocin has superior evidence specifically for pre-operative decolonization

Alternative Systemic Options (If Mupirocin Unavailable)

If mupirocin is truly unavailable, the evidence suggests:

  • Clindamycin achieved 100% eradication in both early and late follow-up 2
  • Ofloxacin achieved 95% eradication at early follow-up and 100% at late follow-up 2
  • Fluoroquinolones (particularly oral levofloxacin) combined with topical gentamicin ointment have been suggested in resource-limited settings 4

Clinical Implementation Algorithm

For surgical patients requiring decolonization:

  1. Screen for nasal S. aureus carriage 1-2 weeks before surgery
  2. If positive: Prescribe mupirocin 2% nasal ointment twice daily for 5 days
  3. Consider adding chlorhexidine gluconate soap (40 mg/mL) for bathing
  4. Complete decolonization as close to surgery as possible (within 1-2 weeks)
  5. If 5-day course incomplete pre-operatively, complete it post-surgery 1

For healthcare workers with persistent nasal carriage:

  • Mupirocin remains first-line
  • Monitor for mupirocin resistance in your institution
  • Consider clindamycin or fluoroquinolones only if mupirocin fails or is contraindicated

Critical Pitfalls to Avoid

  • Do not use oral flucloxacillin for routine decolonization—it lacks supporting evidence for this indication and carries unnecessary risks of drug interactions 5, 3 and adverse events 6
  • Do not implement decolonization without local epidemiology assessment—policies should reflect local S. aureus prevalence and resistance patterns 1
  • Do not neglect standard infection control measures—hand hygiene and surgical technique remain paramount regardless of decolonization status 1
  • Monitor for mupirocin resistance emergence when implementing decolonization programs 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.